Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ND0612H in Advanced Parkinson's Disease
NCT02577523Phase 2Completed
- Sponsor
- NeuroDerm Ltd.
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 4
01
Overview
Phase 2, randomised, single-blind trial of ND0612 in Parkinson's disease (PD), sponsored by NeuroDerm Ltd. Started Dec 2015; status: completed.
02
Drugs
ND0612
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02577523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577523.